Successful treatment of recalcitrant pyoderma gangrenosum with infliximab complicated by tuberculosis despite negative screening tests.
Uthman
I
I
El-Sayad
J
J
Sharara
A
A
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000627:therapeutic use*; D006801:Humans; D000069285:Infliximab; D008297:Male; D009894:Opportunistic Infections / Q000139:chemically induced*; D017511:Pyoderma Gangrenosum / Q000188:drug therapy*; D014391:Tuberculosis, Miliary / Q000139:chemically induced*
D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D000069285:Infliximab